Article
Tau toxicity is gated through the 306VQIVYK311 domain but through mechanisms not entirely dependent on Tau aggregation
2026-05-07
Abstract excerpt
<title>Abstract</title> <p> Disease-modifying therapies for Tauopathies like Alzheimer’s disease have targeted Tau hyperphosphorylation and aggregation, as both pathological manifestations are implicated in Tau-mediated toxicity. More recently there has been a renewed interest in Tau conformation which appears to influence its toxic potential. However, the impact of Tau hyper-phosphorylation on its eventual conf...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5ca98701-3da5-5a19-a8e5-73dde882a3c4
- DOI
- 10.21203/rs.3.rs-8909841/v1
